BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17766436)

  • 1. Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization.
    Partanen JI; Nieminen AI; Mäkelä TP; Klefstrom J
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14694-9. PubMed ID: 17766436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D view to tumor suppression: Lkb1, polarity and the arrest of oncogenic c-Myc.
    Partanen JI; Nieminen AI; Klefstrom J
    Cell Cycle; 2009 Mar; 8(5):716-24. PubMed ID: 19221484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
    Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
    Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes.
    Reginato MJ; Mills KR; Becker EB; Lynch DK; Bonni A; Muthuswamy SK; Brugge JS
    Mol Cell Biol; 2005 Jun; 25(11):4591-601. PubMed ID: 15899862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ; Dickson RB
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P; Russo J; Mgbonyebi OP; Russo IH
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1.
    Xie Z; Zeng X; Waldman T; Glazer RI
    Cancer Res; 2003 Sep; 63(17):5370-5. PubMed ID: 14500370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pim-1 kinase stimulates c-Myc-mediated death signaling upstream of caspase-3 (CPP32)-like protease activation.
    Mochizuki T; Kitanaka C; Noguchi K; Sugiyama A; Kagaya S; Chi S; Asai A; Kuchino Y
    Oncogene; 1997 Sep; 15(12):1471-80. PubMed ID: 9333023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation.
    Anderson LR; Sutherland RL; Butt AJ
    Oncogene; 2010 Jan; 29(4):527-38. PubMed ID: 19881545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
    Gibson EM; Henson ES; Haney N; Villanueva J; Gibson SB
    Cancer Res; 2002 Jan; 62(2):488-96. PubMed ID: 11809700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1.
    Liu XW; Taube ME; Jung KK; Dong Z; Lee YJ; Roshy S; Sloane BF; Fridman R; Kim HR
    Cancer Res; 2005 Feb; 65(3):898-906. PubMed ID: 15705888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells.
    Lucas JJ; Domenico J; Gelfand EW
    Mol Cancer Res; 2004 Feb; 2(2):105-14. PubMed ID: 14985467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers.
    Marques E; Englund JI; Tervonen TA; Virkunen E; Laakso M; Myllynen M; Mäkelä A; Ahvenainen M; Lepikhova T; Monni O; Hautaniemi S; Klefström J
    Oncogene; 2016 Mar; 35(11):1386-98. PubMed ID: 26073086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis.
    Rohn JL; Hueber AO; McCarthy NJ; Lyon D; Navarro P; Burgering BM; Evan GI
    Oncogene; 1998 Dec; 17(22):2811-8. PubMed ID: 9879987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
    LeVea CM; Reeder JE; Mooney RA
    Exp Cell Res; 2004 Jul; 297(1):272-84. PubMed ID: 15194442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cell organization suppresses Myc function by attenuating Myc expression.
    Simpson DR; Yu M; Zheng S; Zhao Z; Muthuswamy SK; Tansey WP
    Cancer Res; 2011 Jun; 71(11):3822-30. PubMed ID: 21610111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quiescence versus apoptosis: Myc abundance determines pathway of exit from the cell cycle.
    Helbing CC; Wellington CL; Gogela-Spehar M; Cheng T; Pinchbeck GG; Johnston RN
    Oncogene; 1998 Sep; 17(12):1491-501. PubMed ID: 9794226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.